Denali reports net loss of $39M in Q1 2019
Denali has reported net loss of $39.0 million in the first quarter 2019, compared with a net loss of $23.7 million same period last year.
Pharmaceuticals, Biotechnology and Life Sciences
Denali has reported net loss of $39.0 million in the first quarter 2019, compared with a net loss of $23.7 million same period last year.
Takeda sells Xiidra to Novartis for up to$5.3 billion, TachoSil to Ethicon for approximately $400 million
Bicycle Therapeutics today announced two senior appointments to facilitateits expanding and advancing clinical pipeline.
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis
Systemic Lupus Erythematosus (SLE), also known as lupus, is a chronic,inflammatory, autoimmune disease affecting 5 million people worldwidewith 70%-90% of these cases appearing in females
SAN FRANCISCO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DNA?src=hash" target="_blank"gt;#DNAlt;/agt;–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Cortexyme, Inc. (Nasdaq: CRTX), a clinical stage biopharmaceutical company pioneering a novel disease-modifying therapeutic approach to…
Fourth-quarter fiscal 2019 revenues of $52.4 billion and full-year fiscal 2019 revenues of $214.3 billion, a full-year increase of 3%.…
LAVAL, Quebec–(BUSINESS WIRE)–BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company), a clinical-stage biopharmaceutical company developing novel therapeutics for…
RICHMOND, Va.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/boardroom?src=hash" target="_blank"gt;#boardroomlt;/agt;–Virginia Bio, the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth…